Benzinga's Top Downgrades - Arrowhead Pharma (NASDAQ:ARWR), Boot Barn Holdings (NYSE:BOOT)

JP Morgan downgraded HB Fuller Co FUL from Overweight to Neutral. H.B. Fuller shares rose 0.46 percent to close at $48.50 on Tuesday.
Analysts at Baird downgraded Boot Barn Holdings Inc BOOT from Outperform to Neutral. Boot Barn shares fell 2.21 percent to $15.96 in pre-market trading.
Berenberg downgraded Freeport-McMoRan Inc FCX from Hold to Sell. Freeport-McMoRan shares rose 3.01 percent to $15.42 in pre-market trading.
Jefferies downgraded W. R. Grace & Co GRA from Buy to Hold. The price target for W. R. Grace has been lowered from $80 to $70. W. R. Grace shares gained 0.92 percent to close at $67.01 on Tuesday.
Analysts at Bernstein downgraded F5 Networks, Inc. FFIV from Outperform to Market Perform. F5 Networks shares rose 0.14 percent to close at $142.81 on Tuesday.
Piper Jaffray downgraded Arrowhead Pharmaceuticals Inc ARWR from Overweight to Neutral. Arrowhead Pharmaceuticals shares fell 59 percent to $1.80 in pre-market trading.
Analysts at DA Davidson downgraded Texas Capital Bancshares Inc TCBI from Buy to Neutral. Texas Capital Bancshares shares gained 0.42 percent to close at $71.60 on Tuesday.
Chardan Capital downgraded Arrowhead Pharmaceuticals Inc ARWR from Buy to Neutral. The price target for Arrowhead Pharmaceuticals has been lowered from $8 to $2. Arrowhead Pharmaceuticals shares fell 59 percent to $1.80 in pre-market trading.
Maxim Group downgraded Mantech International Corp MANT from Buy to Hold. Mantech shares rose 0.74 percent to close at $44.83 on Tuesday.

Market News and Data brought to you by Benzinga APIs